FDA Leadership Crisis Deepens Following High-Profile Firings and Resignations
In a period of unprecedented administrative instability, the U.S. Food and Drug Administration (FDA) faced a wave of high-level departures on Friday as Dr. Tracy Beth Høeg, the agency’s acting drug chief, reported she was terminated after refusing to tender her resignation. The shake-up, which also saw the removal of acting vaccines chief Katherine Szarama…